// App-Quantinova.ai

3548 : Phase Ib study of cabozantinib plus panitumumab in KRAS wild-type (WT) metastatic colorectal cancer (mCRC).

Researchers

Presenter

  • John H. Strickler

Principal Investigators

  • Christel N. Rushing

  • Hope Elizabeth Uronis

  • Michael Morse

  • Gerard C. Blobe

  • Yousuf Zafar

  • Shiaowen David Hsu

  • Christy Arrowood

  • Sherri Haley

  • Evan Dropkin

  • Donna Niedzwiecki

  • Herbert Hurwitz

Medical Centers

  • Duke University Medical Center, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • Cabozantinib

  • panitumumab

Outcome

  • N/A

Study Design

  • Single Arm

  • Cohort

Phase

  • I

Study Id's

  • NCT02008383

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved